The Investigational Drug Steering Committee (IDSC) collaborates with the NCI in the design and prioritization of early phase drug development trials carried out within the Experimental Therapeutics Clinical Trials Network (ETCTN) with agents for which NCI’s Cancer Therapy and Evaluation Program (CTEP) holds an Investigational New Drug (IND) application. The IDSC's membership comprises Principal Investigators of the ETCTN Lead Academic Organizations, additional subject matter experts in trial design, clinical imaging, radiation therapy, pharmacokinetics/pharmacodynamics, cancer omics, health-related quality of life, and biostatistics, as well as patient advocates and NCI staff.
Chair
Funda Meric-Bernstam, M.D.
University of Texas M.D. Anderson Cancer Center
Members
Carol Aghajanian, M.D.
Memorial Sloan Kettering Cancer Center
Susanne Arnold, M.D.
University of Kentucky
Joaquina Baranda, M.D., FACP
University of Kansas Cancer Center
Philippe Bedard, M.D., FRCPC
University Health Network, Princess Margaret Cancer Centre
Chandra Belani, M.D.
Penn State University - Hershey Cancer Institute
Jordan Berlin, M.D., Ph.D.
Vanderbilt University, Ingram Cancer Center
Jan Beumer, Pharm.D., Ph.D., DABT
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
John C. Byrd, M.D.
University of Pittsburgh Medical Center
Michael A. Carducci, M.D.
Johns Hopkins University
William Carson, M.D.
Ohio State University Medical Center
Alice Chen, M.D.
National Cancer Institute, Developmental Therapeutics Clinic
A. Dimitrios Colevas, M.D.
Stanford Cancer Center
Brian A. Costello, M.D.
Mayo Clinic
Kevin Courtney, M.D., Ph.D.
UT Southwestern Medical Center
Alexey V. Danilov, M.D., Ph.D.
City of Hope National Medical Center
Farshid Dayyani, M.D., Ph.D.
UC Irvine Chao Family Comprehensive Cancer Center
Elizabeth Claire Dees, M.D., MSc
University of North Carolina at Chapel Hill
Keith T. Flaherty, M.D.
Massachusetts General Hospital
Elizabeth Fox, M.D.
St Jude Children's Research Hospital
David R. Gandara, M.D.
University of California, Davis Comprehensive Cancer Center
Ryan Gentzler, M.D.
University of Virginia
Steven Grant, M.D.
Virginia Commonwealth University
Marcia Horn, JD
International Cancer Advocacy Network
Salma Jabbour, M.D.
Rutgers Cancer Institute of New Jersey
Donald W. Kufe, M.D.
Dana-Farber Cancer Institute
Jeffrey Lancet, M.D.
H. Lee Moffitt Cancer Center University of South Florida
Primo N. Lara, M.D.
University of California, Davis
Heinz-Josef Lenz, M.D.
USC Norris Comprehensive Cancer Center
Glenn Liu, M.D.
University of Wisconsin, Madison
Patricia M. LoRusso, D.O.
Yale Cancer Center
Devalingam Mahalingam, M.B., B.Ch., B.A.O., Ph.D.
Northwestern University Feinberg School of Medicine
Wells Messersmith, M.D., Ph.D.
University of Colorado Denver
Amit M. Oza, M.D., M.B.B.S., FRCPC
University Health Network, Princess Margaret Cancer Centre
Gina R. Petroni, Ph.D.
University of Virginia Health System
Mitch Phelps, Ph.D.
The Ohio State University Comprehensive Cancer Center
Jimmy Ruiz, M.D.
Wake Forest University School of Medicine
Gary K. Schwartz, M.D.
Case Western Reserve University
Lesley Seymour, M.D., FRCPC
Queen's University
Geoffrey I. Shapiro, M.D., Ph.D.
Dana-Farber Cancer Institute
Yu Shyr, Ph.D.
Vanderbilt University Medical Center
Lillian L. Siu, M.D.
University Health Network, Princess Margaret Cancer Centre
Patty Spears
UNC Lineberger, Komen for the Cure
Naoko Takebe, M.D., Ph.D.
Stephenson Cancer Center, University of Oklahoma
Liza Villaruz, M.D.
University of Pittsburgh Medical Center
James C. Yao, M.D.
University of Texas M.D. Anderson Cancer Center
NCI CCCT Program Director
Wolf Lindwasser, Ph.D.
wolf.lindwasser@nih.gov